← All news
Markets

STAT+: Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say

1 source ·1 article ·Aug 12, 08:30 UTC Neurocrine Biosciences

A newly approved drug for Prader-Willi syndrome, a rare disease that causes an insatiable desire to eat, may be tied to a series of patient deaths, experts say.

Covered by 1 outlet

All coverage · 1 article